NS · Pharmaceuticals

Themis Medicare Ltd (THEMISMED)

Pharmaceuticals & Biotechnology

Themis Medicare Ltd (THEMISMED) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-03, reported market cap is $11.10B, P/E ratio is -78.24, net margin is 2.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for THEMISMED

Market cap

$11.10B

P/E ratio

-78.24

Net margin

2.7%

Themis Medicare Ltd (THEMISMED) — FAQ

What is Themis Medicare Ltd's market cap?

Themis Medicare Ltd (THEMISMED) has a reported market cap of $11.10B (data as of 2026-07-03).

What is THEMISMED's P/E ratio?

The price-to-earnings (P/E) ratio for Themis Medicare Ltd (THEMISMED) is -78.24 (data as of 2026-07-03).

Does Themis Medicare Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Themis Medicare Ltd (THEMISMED). Check the MyAverix Finance app for the latest dividend data.

What sector is Themis Medicare Ltd in?

Themis Medicare Ltd (THEMISMED) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is THEMISMED listed on?

THEMISMED is listed on NS.

What is Themis Medicare Ltd's net margin?

Themis Medicare Ltd (THEMISMED) reports a net margin of 2.7% (data as of 2026-07-03).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)